Banner

Products

All Products Cell Analyzing Tools EzQuant Kits EZQuant Cytotoxicity Assay Kit

EZQuant Cytotoxicity Assay Kit

Catalog# Unit Unit Price (USD) Actions
CA01 500 tests $210.00 Out of Stock
CA04 2000 tests $475.00 Out of Stock
Highlights:
  • High linearity range
  • Long shelf-life without degradation (2 months at 0-5° C)
  • Simple homogenous assay or non-homogenous (multiplex) assay possible
Description:

The EZQuant™ Cytotoxicity Assay Kit is used to assess cell death. It measures the level of LDH released when cells undergo stress or injury from chemicals that are toxic to the cells. The reagent is reduced by NADH that was oxidized by the extracellular LDH. Therefore, the amount of formazan produced is directly proportional to the number of dead cells.

Pair with EZQuant™ Cell Quantifying Kit

The EZQuant™ Cell Quantifying Kit conveniently determines the number of viable cells in cell proliferation and cytotoxicity assays. This product is useful for drug screening and cytotoxicity testing of chemicals. Meanwhile, the EZQuant™ Cytotoxicity Assay Kit determines the number of damaged cells and the degree of cytotoxicity. Combining these two products will allow researchers to fully understand the cell health conditions under various cytotoxic environments.

images/Desc_Images/CA01_1.png
Figure 1. High stability of EZQuant™ reconstituted working solution over a 2-month period.
images/Desc_Images/CA01_2.png
Figure 2. High linearity compared to other competitor products.
Specifications:
Product Name EZQuant Cytotoxicity Assay Kit
Shipping Condition Room Temperature - 2 Day Shipping
Storage and Stability

Store at 0-5° C

Quality Control

Appearance, blank, and sensitivity tests are performed for each lot. Only lots that pass the following criteria are offered: Blank Absorbance (460 nm) ≤ 0.700 Sensitivity Absorbance (460 nm) ≥ 1.000

Restricted Use

For Research Use Only. Not for use in diagnostic or therapeutic procedures.

  1. Peters, Molly C., et al. "A Novel Polyamine-Targeted Therapy for BRAF Mutant Melanoma Tumors." Medical Sciences 6.1 (2018): 3.